<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05076669</url>
  </required_header>
  <id_info>
    <org_study_id>FSK-001</org_study_id>
    <nct_id>NCT05076669</nct_id>
    <nct_alias>NCT05061927</nct_alias>
  </id_info>
  <brief_title>Quality of Life Impact After Enhanced Follow-up of Ostomy Patients</brief_title>
  <acronym>StomaCare</acronym>
  <official_title>Quality of Life Impact After Enhanced Follow-up of Ostomy Patients by a Home Healthcare Nursing Service Employing Stomal Therapy Nurse Consultants Compared to Conventional Care</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>FSK</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>FSK</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this context, FSK would like to implement a clinical study to assess the added value on&#xD;
      the health-related QoL from the enhanced follow-up of ostomy patients by a HHN including&#xD;
      stomal therapists.&#xD;
&#xD;
      The interventional group will benefit from delivery and enhanced follow-up by the FSK HHN&#xD;
      provided, in particular, by stomal therapy nurse consultants and patient-relation experts&#xD;
      during in-person or remote appointments in addition to the routine care delivered and&#xD;
      prescribed by the sites.&#xD;
&#xD;
      The control group will receive the routine care prescribed by the sites and will be provided&#xD;
      with ostomy equipment by FSK.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      France currently has about 80,000 ostomy patients. Stoma placement exposes patients to many&#xD;
      surgical or peristomal skin complications which could impair the quality of life of the&#xD;
      ostomy patient.&#xD;
&#xD;
      The management of ostomy patients varies from institution to institution and according to how&#xD;
      the patient's medical equipment is supplied as well as whether or not specialised personnel&#xD;
      are available.&#xD;
&#xD;
      In the last decade, the market for stoma therapy in France has evolved, with a significant&#xD;
      increase in the delivery of equipment by HHNs, meeting a need for patient follow-up and&#xD;
      accompaniment.&#xD;
&#xD;
      This increased preference of HHNs to use specialist nurses seems to be explained by the added&#xD;
      benefits. Early international studies have demonstrated the impact of an enterostomal therapy&#xD;
      nurse follow-up on the improvement of ostomy patient's quality of life (QoL) relative to&#xD;
      their health.&#xD;
&#xD;
      However, none of the studies available today on follow-ups performed by an enterostomal&#xD;
      therapist included the French population. Furthermore, the studies show methodological gaps,&#xD;
      a limited time span and are based on strong hypotheses.&#xD;
&#xD;
      In this context, FSK would like to implement a clinical study to assess the added value on&#xD;
      the health-related QoL from the enhanced follow-up of ostomy patients by a HHN including&#xD;
      stomal therapists.&#xD;
&#xD;
      The interventional group will benefit from delivery and enhanced follow-up by the FSK HHN&#xD;
      provided, in particular, by stomal therapy nurse consultants and patient-relation experts&#xD;
      during in-person or remote appointments in addition to the routine care delivered and&#xD;
      prescribed by the sites.&#xD;
&#xD;
      The control group will receive the routine care prescribed by the sites and will be provided&#xD;
      with ostomy equipment by FSK.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 2021</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">August 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Open-label, randomised, comparative, controlled, national and multi-centre study with minimal risks and constraints to routine care.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy</measure>
    <time_frame>3 months</time_frame>
    <description>score from the Stoma-QOL specific questionnaire (min: 0- max: 100), analysis of the mean</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Satisfaction of patient</measure>
    <time_frame>3 and 6 months</time_frame>
    <description>scale 0-100</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>1, 2, 3 and 6 months</time_frame>
    <description>Stoma-QOL questionnaire, (min: 0- max: 100), analysis of the mean</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>1, 2, 3 and 6 months</time_frame>
    <description>EQ-5D-5L questionnaire (min: 0- max: 1), analysis of the mean</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost</measure>
    <time_frame>3 and 6 months</time_frame>
    <description>• Calculation of resource use at 3 and 6 months per expenditure item (use of services, drug use, medical device and home healthcare service use, MCO (Médecine chirurgie obstétrique [Obstetric surgery]) hospitalisations and SSR (Soins de suite et de réadaptation [Follow-up care and rehabilitation]) hospitalisations) for each group.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Morbidity</measure>
    <time_frame>3 and 6 months</time_frame>
    <description>readmission rate</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">350</enrollment>
  <condition>Stoma Ileostomy</condition>
  <condition>Stoma Colostomy</condition>
  <condition>Quality of Life</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The control group will receive the routine care prescribed by the sites and will be provided with ostomy equipment by FSK.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>interventional group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The interventional group will benefit from delivery and enhanced follow-up by the FSK HHN provided, in particular, by stomal therapy nurse consultants and patient-relation experts during in-person or remote appointments in addition to the routine care delivered and prescribed by the sites.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>stoma follow-up</intervention_name>
    <description>delivery and enhanced follow-up by the FSK HHN provided, in particular, by stomal therapy nurse consultants and patient-relation experts during in-person or remote appointments in addition to the routine care delivered and prescribed by the sites</description>
    <arm_group_label>interventional group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>standard of care</intervention_name>
    <description>routine management of stoma</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male or female ≥ 18 years&#xD;
&#xD;
          -  Patients with a stoma placed less than 10 days ago&#xD;
&#xD;
          -  Patients who had a stoma during their current hospitalisation&#xD;
&#xD;
          -  Patients informed verbally and in writing via the information sheet and who signed the&#xD;
             informed consent form.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients in palliative care&#xD;
&#xD;
          -  Patients participating in another clinical study interested in the management of&#xD;
             ostomy patients&#xD;
&#xD;
          -  Patients not enrolled in a social security system or with the CMU (Couverture maladie&#xD;
             universelle [Universal Health Coverage])&#xD;
&#xD;
          -  Patients under judicial protection or under guardianship&#xD;
&#xD;
          -  Patients deprived of freedom (in prison and psychiatric patients being treated without&#xD;
             consent)&#xD;
&#xD;
          -  Patients with difficulties understanding or reading French&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeremie H Lefevre, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sorbonne University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ingrid Kuhn</last_name>
    <phone>+33 7 61 47 98 25</phone>
    <email>i.kuhn@fsk.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hopital Bicètre</name>
      <address>
        <city>Le Kremlin-Bicêtre</city>
        <zip>93043</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Lyon-Sud</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Eddy Cotte, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Eddy Cotte, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital SAint Louis</name>
      <address>
        <city>Paris</city>
        <zip>75009</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Alexandra Masson-Lecomte, MD</last_name>
    </contact>
    <investigator>
      <last_name>Alexandra Masson-Lecomte</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital Saint-Louis</name>
      <address>
        <city>Paris</city>
        <zip>75009</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Saint-Antoine</name>
      <address>
        <city>Paris</city>
        <zip>75012</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Jeremie Lefevre</last_name>
    </contact>
    <investigator>
      <last_name>Jeremie H Lefevre, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital de la Pitié-Salpétrière</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital HEGP</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ESPIC FOCH - Digestige Unit</name>
      <address>
        <city>Suresnes</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ESPIC Foch - Urology Unit</name>
      <address>
        <city>Suresnes</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Yann Neuzillet, MD,PhD</last_name>
    </contact>
    <investigator>
      <last_name>Yann Neuzillet, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Toulouse</name>
      <address>
        <city>Toulouse</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Mathieu Roumiguié, MD</last_name>
    </contact>
    <investigator>
      <last_name>Mathieu Roumiguié, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <link>
    <url>http://fsk.fr</url>
    <description>Website of FSK</description>
  </link>
  <reference>
    <citation>Becker A, Schulten-Oberbörsch G, Beck U, Vestweber KH. Stoma care nurses: good value for money? World J Surg. 1999 Jul;23(7):638-42; discussion 642-3.</citation>
    <PMID>10390579</PMID>
  </reference>
  <results_reference>
    <citation>Persson E, Berndtsson I, Carlsson E, Hallén AM, Lindholm E. Stoma-related complications and stoma size - a 2-year follow up. Colorectal Dis. 2010 Oct;12(10):971-6. doi: 10.1111/j.1463-1318.2009.01941.x.</citation>
    <PMID>19519689</PMID>
  </results_reference>
  <results_reference>
    <citation>Neil N, Inglese G, Manson A, Townshend A. A Cost-Utility Model of Care for Peristomal Skin Complications. J Wound Ostomy Continence Nurs. 2016 Jan-Feb;43(1):62-8. doi: 10.1097/WON.0000000000000194.</citation>
    <PMID>26633166</PMID>
  </results_reference>
  <results_reference>
    <citation>Marquis P, Marrel A, Jambon B. Quality of life in patients with stomas: the Montreux Study. Ostomy Wound Manage. 2003 Feb;49(2):48-55.</citation>
    <PMID>12598701</PMID>
  </results_reference>
  <results_reference>
    <citation>Danielsen AK, Rosenberg J. Health related quality of life may increase when patients with a stoma attend patient education--a case-control study. PLoS One. 2014 Mar 7;9(3):e90354. doi: 10.1371/journal.pone.0090354. eCollection 2014.</citation>
    <PMID>24609004</PMID>
  </results_reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 21, 2021</study_first_submitted>
  <study_first_submitted_qc>September 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 13, 2021</study_first_posted>
  <last_update_submitted>September 29, 2021</last_update_submitted>
  <last_update_submitted_qc>September 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

